Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic
Journal of Affective Disorders · 2023-02 · 322 · 52-62
DOI: 10.1016/j.jad.2022.11.021 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2023-02. Verfasst von Hailey Meaklim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia. Hauptthemen laut MEDLINE: COVID-19, Sleep Initiation and Maintenance Disorders. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Monash University.
Themen: Depression, Schlaf
Abstract (Originalsprache)
BACKGROUND: Insomnia is a risk factor for affective disorders. This study examined whether individuals with insomnia symptoms early in the pandemic, either pre-existing or new-onset, were more vulnerable to anxiety and depressive symptoms over time than those who maintained normal sleep. Additionally, sleep-related factors such as pre-sleep arousal were assessed for their influence on clinically significant anxiety and depression risk. METHODS: Using a global online survey with 3-, 6-, and 12-month follow-ups between April 2020 and May 2021, data from 2069 participants (M = 46.16 ± 13.42 years; 75.3 % female) with pre-existing, new-onset, or no insomnia symptoms was examined using mixed-effects and logistic regression models. RESULTS: New-onset and pre-existing insomnia predicted persistent anxiety and depressive symptoms longitudinally (p's < 0.001), over other known risk factors, including age, sex, and previous psychiatric diagnoses. Anxiety and depressive symptoms in both insomnia groups remained above clinically significant thresholds at most time points, whereas normal sleepers remained subclinical. Pre-sleep arousal was found to increase the risk of clinically significant anxiety (OR = 1.05) and depressive symptoms (OR = 1.09) at 12-months. Sleep effort contributed to anxiety (OR = 1.06), whereas dysfunctional sleep-related beliefs and attitudes predicted clinically significant depression (OR = 1.22). LIMITATIONS: Insomnia group categorization was based on self-report at baseline supported by a validated measure. High participant attrition was observed at 3-months (53 %; n = 971), but retention remained steady till 12-months (63 %, n = 779). CONCLUSIONS: Insomnia is a modifiable risk factor for persistent anxiety and depressive symptoms that needs to be addressed in mental healthcare. Additionally, pre-sleep arousal may be an important transdiagnostic process linking insomnia with affective disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia.
- Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia; Department of Psychology, University of Oregon, Eugene, OR, USA; The Sleep Health Foundation, Black…
- Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia; School of Educational Psychology and Counselling, Faculty of Education, Monash University, Victoria…
- School of Educational Psychology and Counselling, Faculty of Education, Monash University, Victoria, Australia.
- Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia. Electronic address: melinda.jackson@monash.edu.
Förderung
- Monash University
Zitieren
APA
Meaklim, H., Saunders, W. J., Byrne, M. L., Junge, M. F., Varma, P., Finck, W. A., & Jackson, M. L. (2023). Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic. Journal of Affective Disorders, 322, 52-62. https://doi.org/10.1016/j.jad.2022.11.021
Vancouver
Meaklim H, Saunders WJ, Byrne ML, Junge MF, Varma P, Finck WA, et al. Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic. Journal of Affective Disorders. 2023;322:52-62. doi:10.1016/j.jad.2022.11.021
BibTeX
@article{Meaklim2023,
author = {Meaklim, Hailey and Saunders, William J and Byrne, Michelle L and Junge, Moira F and Varma, Prerna and Finck, Wendy A and Jackson, Melinda L},
title = {Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic},
journal = {Journal of Affective Disorders},
year = {2023},
volume = {322},
pages = {52--62},
doi = {10.1016/j.jad.2022.11.021}
}
EUVIMED